Cancer
Diabetic Ketoacidosis Risk Factors Identified in Hematologic Malignancy Patients
Researchers from the City of Hope have identified a unique set of risk factors for diabetic ketoacidosis (DKA) in patients with hematologic malignancies, particularly those undergoing high-intensity treatment. The findings highlight the importance of close clinical and laboratory monitoring to facilitate rapid diagnosis and treatment of DKA. According to the